IFP Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-35,212
Closed -$3.48M 3351
2019
Q3
$3.48M Buy
+35,212
New +$3.35M 0.23% 100
2019
Q1
$2.4M Sell
25,519
-23,779
-48% -$2.08M 0.33% 70
2018
Q4
$3.08M Sell
49,298
-9,172
-16% -$677K 0.19% 127
2018
Q3
$5.23M Buy
58,470
+7,026
+14% +$621K 0.21% 103
2018
Q2
$4.09M Buy
51,444
+5,836
+13% +$485K 0.17% 136
2018
Q1
$4.76M Hold
45,608
0.22% 96
2017
Q4
$4.76M Sell
45,608
-5,638
-11% -$636K 0.22% 96
2017
Q3
$7.47M Buy
51,246
+10,394
+25% +$1.42M 0.3% 69
2017
Q2
$5.3M Sell
40,852
-6,161
-13% -$755K 0.22% 99
2017
Q1
$5.85M Sell
47,013
-1,172
-2% -$140K 0.25% 84
2016
Q4
$5.58M Buy
48,185
+13,889
+40% +$1.55M 0.27% 75
2016
Q3
$3.58M Buy
34,296
+1,790
+6% +$194K 0.19% 114
2016
Q2
$3.21M Buy
32,506
+6,987
+27% +$723K 0.18% 114
2016
Q1
$2.4M Sell
25,519
-10,601
-29% -$1.09M 0.33% 70
2015
Q4
$4.33M Buy
+36,120
New +$4.18M 0.29% 74

Other funds holding CELG

IFP Advisors's CELG Position: Q4 2019 in Review

IFP Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 35,212 shares — an estimated $3.48M sold.

IFP Advisors first reported a position in CELG in Q4 2015 and held it in 15 quarters. The position peaked at $7.47M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • IFP Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • IFP Advisors sold 35,212 Celgene Corp shares in Q4 2019, an estimated $3.48M.
  • IFP Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 15 quarters.
  • IFP Advisors's Celgene Corp position peaked at $7.47M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on IFP Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.